Hepatosplanchnic clearance of interleukin-6 in humans during exercise

被引:78
作者
Febbraio, MA [1 ]
Ott, P
Nielsen, HB
Steensberg, A
Keller, C
Krustrup, P
Secher, NH
Pedersen, BK
机构
[1] RMIT Univ, Sch Med Sci, Skeletal Muscle Res Lab, Bundoora, Vic 3083, Australia
[2] Rigshosp, Copenhagen Muscle Res Ctr, DK-2200 Copenhagen, Denmark
[3] Rigshosp, Dept Hepatol, DK-2200 Copenhagen, Denmark
[4] Rigshosp, Dept Infect Dis, DK-2200 Copenhagen, Denmark
[5] Rigshosp, Dept Anesthesia, DK-2200 Copenhagen, Denmark
[6] Univ Copenhagen, August Krogh Inst, DK-2200 Copenhagen, Denmark
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2003年 / 285卷 / 02期
关键词
liver; cytokine; metabolism; skeletal muscle contraction; blood flow;
D O I
10.1152/ajpendo.00134.2003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cytokine interleukin (IL)-6 can increase markedly in the circulation during exercise, but whether the liver is a source of this increase is unknown. The aim of this study was to measure IL-6 flux across the hepatosplanchnic tissues in humans. To elevate systemic concentrations of IL-6, six healthy male subjects performed 120 min of semirecumbent cycling, and blood samples were simultaneously obtained from a brachial artery and the hepatic vein before and during exercise for the analysis of IL-6. Hepatosplanchnic blood flow ( HBF) was measured using the indocyanine green infusion technique. Net hepatosplanchnic IL-6 balance was calculated from these measures. HBF was 1.3 +/- 0.1 l/min at rest and was not reduced throughout exercise, averaging 1.1 +/- 0.2 l/min. Arterial plasma IL-6 markedly increased ( P < 0.05) from 1.8 +/- 0.6 ng/l at rest to 14.3 +/- 3.2 ng/l after 120 min of exercise. The hepatosplanchnic viscera did not contribute to this increase, since there was a net hepatosplanchnic IL-6 uptake ( 0.8 +/- 0.3 vs. 5.5 +/- 1.9 ng/min, rest vs. 120 min; P < 0.05). These data demonstrate that the hepatosplanchnic viscera remove IL-6 from the circulation in humans. This removal may constitute a mechanism limiting the negative chronic metabolic action of chronically elevated circulating IL-6.
引用
收藏
页码:E397 / E402
页数:6
相关论文
共 46 条
[1]  
ANDUS T, 1991, HEPATOLOGY, V13, P364, DOI 10.1016/0270-9139(91)92454-G
[2]   PLASMA-CLEARANCE, ORGAN DISTRIBUTION AND TARGET-CELLS OF INTERLEUKIN-6 HEPATOCYTE-STIMULATING FACTOR IN THE RAT [J].
CASTELL, JV ;
GEIGER, T ;
GROSS, V ;
ANDUS, T ;
WALTER, E ;
HIRANO, T ;
KISHIMOTO, T ;
HEINRICH, PC .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 177 (02) :357-361
[3]  
DEVIERE J, 1989, CLIN EXP IMMUNOL, V77, P221
[4]   Autocrine up-regulation of glucocorticoid receptors by interleukin-6 in human osteoblast-like cells [J].
Dovio, A ;
Masera, RG ;
Sartori, ML ;
Racca, S ;
Angeli, A .
CALCIFIED TISSUE INTERNATIONAL, 2001, 69 (05) :293-298
[5]   Cytokines and type 2 diabetes mellitus [J].
Dovio, A ;
Angeli, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18) :2233-2233
[6]   Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans [J].
Febbraio, MA ;
Steensberg, A ;
Keller, C ;
Starkie, RL ;
Nielsen, HB ;
Krustrup, P ;
Ott, P ;
Secher, NH ;
Pedersen, BK .
JOURNAL OF PHYSIOLOGY-LONDON, 2003, 549 (02) :607-612
[7]   Muscle-derived interleukin-6: mechanisms for activation and possible biological roles [J].
Febbraio, MA ;
Pedersen, BK .
FASEB JOURNAL, 2002, 16 (11) :1335-1347
[8]  
FEBBRAIO MA, IN PRESS METABOLISM
[9]  
Galbo H., 1983, HORMONAL METABOLIC A
[10]   The role of cytokines in liver failure and regeneration: Potential new molecular therapies [J].
Galun, E ;
Axelrod, JH .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2002, 1592 (03) :345-358